Article
Development and Validation of a New Mouse Model to Investigate the Role of SV2A in Epilepsy.
PloS one - 1 Jan 2016
Menten-Dedoyart Catherine, Serrano Navacerrada Maria Elisa, Bartholome Odile, Sánchez Gil Judit, Neirinckx Virginie, Wislet Sabine, Becker Guillaume, Plenevaux Alain, Van den Ackerveken Priscilla, Rogister Bernard
Abstract excerpt
SV2A is a glycoprotein present in the membranes of most synaptic vesicles. Although it has been highly conserved throughout evolution, its physiological role remains largely unknown. Nevertheless, Levetiracetam, a very effective anti-epileptic drug, has been recently demonstrated to bind to SV2A. At present, our understanding of the normal function of SV2A and its possible involvement in diseases like epilepsy is...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
